Day: February 27, 2025

Exceeds the mid-point of fourth quarter revenue guidance, achieves record gross margin on the full year, and delivers strong cash flow generation Fourth Quarter 2024 Financial HighlightsRevenue of $275.2 million Gross Margin of 28.5% Adjusted gross margin(1) of 29.8% Net loss to common shareholders of $(141.2) millionNet loss to common shareholders inclusive of $74.0 million non-cash goodwill impairment charge and $91.9 million non-cash long-lived intangible asset write-down associated with the 2022 STI acquisitionAdjusted EBITDA(1) of $45.2 million Net loss per basic and diluted share of $(0.93) Adjusted net income per diluted share(1) of $0.16Full Year 2024 Financial HighlightsRevenue of $915.8 million Gross Margin of 32.5% Adjusted gross margin (1) of 34.1% Net loss to common shareholders of $(296.1) millionNet loss to...

Company to Host Quarterly Conference Call at 5:00 P.M. ET on February 27, 2025The information in this press release should be read in conjunction with an earnings presentation that is available on the Company’s website at investors.amcoastal.com/Presentations. ST. PETERSBURG, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) — American Coastal Insurance Corporation (Nasdaq: ACIC) (“ACIC” or the “Company”), a property and casualty insurance holding company, today reported its financial results for the fourth quarter and year ended December 31, 2024.       ($ in thousands, except for per share data)Three Months Ended   Year EndedDecember 31,   December 31,    2024       2023     Change     2024       2023     ChangeGross premiums written $ 140,739     $ 128,260     9.7 %   $ 647,805     $ 635,709     1.9 %Gross...

SAN FRANCISCO, Feb. 27, 2025 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its fourth quarter and year ended December 31, 2024. Opendoor’s fourth quarter and year-end 2024 financial results and management commentary can be accessed through the Company’s shareholder letter on the “Quarterly Reports” page of Opendoor’s investor relations website at https://investor.opendoor.com/financials-filings/quarterly-reports. “In 2024, we took decisive actions to streamline operations and optimize our cost structure to better position the Company to navigate the persistent housing market headwinds and drive toward our longer-term profitability target. As a result, we significantly reduced Adjusted Net Losses in...

FY Revenue of $291.3 million, up 9% over 2023; Delivered FY 2024 net income of $12.5 million or 4% margin; FY adjusted EBITDA increased 23% over 2023 and was $92.3 million or 32% margin; Revenue in Q4 from CTV more than doubled year over year and represented 20% of total revenue; Supply Path Optimization represented 53% of total activity in 2024; Repurchased 4.3 million shares in 2024, representing 7.9% of fully diluted shares as of December 31, 2024 NO-HEADQUARTERS/REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) — PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today reported financial results for the fourth quarter and fiscal year ended December 31, 2024. “Revenue growth in the year more than doubled over 2023, driven by strength in CTV, emerging...

– Robust initial efficacy signal with onvansertib + chemo/bev in ongoing first-line RAS-mut metastatic colorectal cancer (“mCRC”) clinical trial (CRDF-004) – – Priced oversubscribed $40 million underwritten registered direct offering with participation from new and existing healthcare dedicated investors –  – Issuance of new patent with claims for the use of onvansertib for treating KRAS-mut mCRC – – Cash and equivalents of $91.7 million as of December 31, 2024, projected runway into Q1 2027 – – Company will hold a conference call today at 4:30 p.m. ET/1:30 p.m. PT – SAN DIEGO, Feb. 27, 2025 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers,...

Fourth Quarter Revenue Increased 30% to a Record $19.6 Million, Producing $6.7 Million of Cash Flow from Operations Full Year 2024 Revenue Increased 25% to $75.2 Million, Generating GAAP EPS of $0.50 BOCA RATON, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the fourth quarter and full year ended December 31, 2024. “We are proud to announce record-breaking financial results for 2024, including record revenue in the fourth quarter, which marks a significant achievement as we defied the historic seasonality we typically experience during that quarter,” stated Derek Dubner, red violet’s CEO. “The market is recognizing what we have known all along—we have built the leading technology platform with superior solutions...